Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the panic attack treatment market size changed in recent years, and what is the outlook ahead?
The panic attack treatment market size has grown rapidly in recent years. It will grow from $3.04 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to increasing public stigma reduction toward mental health conditions, a rise in awareness campaigns led by health organizations, increasing diagnosis rates of anxiety disorders in developed regions, inclusion of mental health in primary healthcare settings, and expansion of private mental health clinics.
The panic attack treatment market size is expected to see rapid growth in the next few years. It will grow to $6.86 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the rising prevalence of anxiety and panic disorders across all age groups, the growing adoption of telehealth and digital therapy apps, the increasing focus on personalized and precision psychiatry, the increasing investments in mental health startups and innovations, and the enhanced public-private partnerships in mental health service delivery. Major trends in the forecast period include mainstream adoption of virtual reality-based exposure therapy, a surge in mobile apps for cognitive behavioral therapy delivery, a shift toward holistic and integrative treatment approaches, growing use of wearable biosensors for real-time anxiety tracking, and incorporation of mindfulness and meditation in clinical regimens.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24356&type=smp
What are the top economic and technological drivers pushing panic attack treatment market growth?
The increasing prevalence of anxiety is expected to propel the growth in the panic attack treatment market going forward. Anxiety is a mental health condition characterized by persistent feelings of worry, nervousness, and fear, often accompanied by physical symptoms such as restlessness, rapid heartbeat, and difficulty concentrating. The pressures of modern life contribute to rising anxiety levels by creating constant demands for productivity, financial stability, and social success, leaving little time for rest or emotional recovery. Panic attack treatment addresses anxiety by offering effective solutions to alleviate symptoms, improve emotional well-being, and help individuals regain control of their lives through personalized and timely interventions. For instance, in May 2024, according to the American Psychiatric Association (APA), a US-based medical specialty society representing psychiatrists nationwide, a growing percentage of U.S. adults report feeling more anxious, with 43% in 2024 expressing higher anxiety levels compared to 37% in 2023 and 32% in 2022. Therefore, the increasing prevalence of anxiety is driving the panic attack treatment market.
How is the panic attack treatment market segmented by product, application, and end-user?
The panic attack treatment market covered in this report is segmented –
1) By Treatment Type: Cognitive Behavioral Therapy (CBT), Medications, Other Treatment Types
2) By Drug Class: Antidepressants, Anti-Anxiety Drugs, Calcitonin Gene-Related Peptide (CGRP) Antagonists, Other Drug Classes
3) By Route Of Administration: Oral, Intravenous, Intramuscular, Sublingual, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Hospitals, Mental Healthcare Centers, Other Applications
Subsegments:
1) By Cognitive Behavioral Therapy (CBT): Exposure Therapy, Dialectical Behavior Therapy (DBT), Acceptance And Commitment Therapy (ACT), Mindfulness-Based Cognitive Therapy (MBCT), Rational Emotive Behavior Therapy (REBT)
2) By Medications: Beta Blockers, Buspirone, Anticonvulsants, Atypical Antipsychotics, Herbal And Natural Supplements
3) By Other Treatment Types: Telepsychiatry, Biofeedback And Neurofeedback, Virtual Reality Therapy, Mobile Health Applications, Support Groups And Counseling Services
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/panic-attack-treatment-global-market-report
What technological trends are expected to redefine the panic attack treatment market?
Major companies operating in the panic attack treatment market are focusing on developing advancements in medical technology, such as digital anxiety relief platforms, to enhance the management of anxiety and panic attacks through accessible, technology-driven solutions. Digital anxiety relief platforms are technology-based applications or services designed to help individuals manage and reduce anxiety through tools such as guided meditation, cognitive behavioral therapy modules, mood tracking, and relaxation exercises. For instance, in October 2024, CalmiGo, a US-based mental health startup, launched CalmiGo Plus, an advanced digital platform designed to support users in managing anxiety and panic attacks more effectively. The platform includes a patented, sensor-based exhaler device and a companion mobile application that leverages gamification and personalized therapeutic techniques to improve mental health outcomes. This innovation enables users to receive immediate, drug-free relief while also tracking progress over time, reflecting a significant step forward in accessible and data-driven anxiety treatment solutions.
Which leading companies are dominating the panic attack treatment market landscape?
Major companies operating in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Shionogi & Co. Ltd., Lundbeck A/S, Recordati Rare Diseases, Torrent Pharmaceuticals Ltd.
Which geographic areas are expected to offer the highest growth opportunities in thepanic attack treatment market?
North America was the largest region in the panic attack treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic attack treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Panic Attack Treatment Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24356&type=smp
Need Customized Data On Panic Attack Treatment Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24356&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
